Sonsini Peter W.

Average Profitability
<0.0001%
Insider Buys Quantity
22
Insider Buys Sum
$305.91M
Insider Sells Quantity
4
Insider Sells Sum
$134.97M

Insider Activity of Sonsini Peter W.

The largest purchase of all time was on 2018-09-07 and amounted to 30000000 shares of Adaptimmune Therapeutics plc for $50M.

The largest sale of all time was on 2017-11-20 and amounted to 5641032 shares of Appian Corporation for $109.94M.

Biography of Sonsini Peter W.

No biography is available at this moment.

2022-05-26SaleIonQ, Inc.
IONQ
498,614
0.2478%
$5.65$2.82M-11.28%
2022-04-11PurchaseTrevi Therapeutics, Inc.
TRVI
948,948
1.1133%
$1.90$1.8M-15.26%
2021-10-18PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
1.85M
11.1305%
$1.62$3M+63.35%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
10 percent owner
1.05M
20.5778%
$19.00$19.95M-7.95%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
10 percent owner
5.71M
9.5207%
$1.75$10M-4.3%
2020-12-04PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
4.4M
7.578%
$0.62$2.74M+22.37%
2020-07-28PurchaseInozyme Pharma, Inc.
INZY
10 percent owner
250,000
1.2168%
$16.00$4M+19.03%
2020-07-14PurchaseNkarta, Inc.
NKTX
10 percent owner
1.33M
2.1488%
$18.00$24M-11.28%
2020-04-03SaleTrevi Therapeutics, Inc.
TRVI
10 percent owner
1,128
0.0062%
$2.66$3,000+19.07%
2020-01-24PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
7.5M
1.0346%
$0.67$5M+34.69%
2019-07-22PurchaseMirum Pharmaceuticals, Inc.
MIRM
10 percent owner
900,000
5.3814%
$15.00$13.5M+5.09%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
5M
34.6117%
$10.00$50M-42.9%
2019-05-07PurchaseRegulus Therapeutics Inc.
RGLS
10 percent owner
1.14M
6.1239%
$1.08$1.23M-40%
2018-09-07PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
30M
4.8721%
$1.67$50M-57.66%
2018-03-27PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
12M
2.1988%
$1.92$23M-12.28%
2018-03-26PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
1.14M
0.2007%
$1.90$2.18M-14.01%
2018-03-23PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
588,180
0.1062%
$1.95$1.14M-12.52%
2018-03-22PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
1.74M
0.308%
$1.90$3.31M-12.12%
2018-03-21PurchaseAdaptimmune Therapeutics plc
ADAP
10 percent owner
209,688
0.0355%
$1.81$379,640-10.61%
2017-11-27SaleAppian Corporation
APPN
10 percent owner
1.14M
2.1156%
$19.49$22.2M+42.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.